132 related articles for article (PubMed ID: 1664810)
21. Prognosis of peripheral lung tumours related to size of the primary.
Treasure T; Belcher JR
Thorax; 1981 Jan; 36(1):5-8. PubMed ID: 7292381
[TBL] [Abstract][Full Text] [Related]
22. Associated primary esophageal and lung carcinoma: a study of 39 patients.
Fékété F; Sauvanet A; Kaisserian G; Jauffret B; Zouari K; Berthoux L; Flejou JF
Ann Thorac Surg; 1994 Sep; 58(3):837-42. PubMed ID: 7524458
[TBL] [Abstract][Full Text] [Related]
23. Surgically resected lung cancer in young adults.
Sugio K; Ishida T; Kaneko S; Yokoyama H; Sugimachi K
Ann Thorac Surg; 1992 Jan; 53(1):127-31. PubMed ID: 1309414
[TBL] [Abstract][Full Text] [Related]
24. Extended operation for T4 lung carcinoma.
Shirakusa T; Kawahara K; Iwasaki A; Okabayashi K; Shiraishi T; Yoneda S; Yoshinaga Y; Matsuzoe D; Watanabe K
Ann Thorac Cardiovasc Surg; 1998 Jun; 4(3):110-8. PubMed ID: 9660907
[TBL] [Abstract][Full Text] [Related]
25. Human lung tumours: does intermediate filament co-expression correlate with other morphological or immunocytochemical features?
Gatter KC; Dunnill MS; Heryet A; Mason DY
Histopathology; 1987 Jul; 11(7):705-14. PubMed ID: 3040564
[TBL] [Abstract][Full Text] [Related]
26. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung.
Yamada H; Ishihara H; Kitagawa H; Kawabata Y; Itoyama S; Sugawara I
Cancer Res; 1992 Aug; 52(16):4408-12. PubMed ID: 1322788
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of neural-cadherin in pulmonary epithelial tumours.
Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
[TBL] [Abstract][Full Text] [Related]
28. [Results of surgical treatment of stage I lung cancer].
Shimizu J; Watanabe Y; Oda M; Hayashi Y; Ota Y; Morita K; Arano Y
Nihon Geka Gakkai Zasshi; 1993 May; 94(5):505-10. PubMed ID: 8392659
[TBL] [Abstract][Full Text] [Related]
29. Role of metallothionein expression in non-small cell lung carcinomas.
Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in the surgical treatment of lung cancer].
Davydov MI; Polotskiĭ BE; Malaev SG; Smirnova EA; Machaladze ZO
Khirurgiia (Mosk); 1996; (1):13-6. PubMed ID: 8683911
[TBL] [Abstract][Full Text] [Related]
31. Surgical treatment of lung cancer. Five-year follow-up of 266 patients.
Fuller J
Minn Med; 1973 Dec; 56(12):1024-6. PubMed ID: 4357301
[No Abstract] [Full Text] [Related]
32. The influence of cell type and lymph node metastases on survival of patients with carcinoma of the lung undergoing thoracotomy.
Rubinstein I; Baum GL; Kalter Y; Pauzner Y; Lieberman Y; Bubis JJ
Am Rev Respir Dis; 1979 Feb; 119(2):253-62. PubMed ID: 219736
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients.
Shiba M; Kakizawa K; Kohno H; Shibuya K; Yamakawa H; Hiroshima K; Fujisawa T
Ann Thorac Surg; 2001 Jun; 71(6):1765-71. PubMed ID: 11426745
[TBL] [Abstract][Full Text] [Related]
34. [Extensive and combined resections in poorly differentiated lung cancer].
Shalaev SA; Grishakov SV; Shnitko SN; Chalisov IA; Starikov VA
Vestn Khir Im I I Grek; 1992 Apr; 148(4):43-9. PubMed ID: 1338884
[TBL] [Abstract][Full Text] [Related]
35. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
Komaki R; Milas L; Ro JY; Fujii T; Perkins P; Allen P; Sikes CR; Mountain CF; Ordonez NG
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):787-96. PubMed ID: 9531362
[TBL] [Abstract][Full Text] [Related]
36. Tumor doubling time and survival of men with bronchogenic carcinoma.
Weiss W
Chest; 1974 Jan; 65(1):3-8. PubMed ID: 4358467
[No Abstract] [Full Text] [Related]
37. Assessment of the role of surgery for control of lung cancer.
Mountain CF
Ann Thorac Surg; 1977 Oct; 24(4):365-73. PubMed ID: 199119
[TBL] [Abstract][Full Text] [Related]
38. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
Oka K; Nakano T; Hoshi T
Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
[TBL] [Abstract][Full Text] [Related]
39. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
40. [Histological structure and tumor size as prognostic factors in the surgical treatment of patients with peripheral lung cancer].
Drukin EIa; Karaseva NA
Vestn Khir Im I I Grek; 1985 Sep; 135(9):14-7. PubMed ID: 3000050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
